Jennifer Woyach
Clinical trials sponsored by Jennifer Woyach, explained in plain language.
-
New drug combo shows promise for leukemia patients
Disease control CompletedThis early-phase study tested a combination of two drugs, daratumumab and ibrutinib, in 15 people with untreated chronic lymphocytic leukemia (CLL) who needed therapy. The goal was to see if the combination is safe and how well it works at controlling the disease. Participants re…
Phase: PHASE1 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a Drug-Vaccine combo delay leukemia in High-Risk patients?
Disease control CompletedThis phase 2 trial tested whether giving the targeted drug ibrutinib along with standard vaccines (pneumonia, flu, and Tdap) can help people with early-stage, high-risk chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) stay progression-free longer. The study …
Phase: PHASE2 • Sponsor: Jennifer Woyach • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC